Burles Johnson
Overview
Explore the profile of Burles Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
10
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baraban E, Vlachou E, Patel S, Kates M, Johnson B, Smith A, et al.
Prostate
. 2025 Jan;
85(5):443-447.
PMID: 39748460
Background: The Nectin-4 directed antibody drug conjugate enfortumab vedotin (EV) has emerged as frontline systemic therapy in combination with immune checkpoint blockade for urothelial carcinoma (UC), capitalizing on the ubiquitous...
2.
Mau B, Johnson B, Hansel D, McConkey D
Semin Radiat Oncol
. 2022 Dec;
33(1):1-11.
PMID: 36517188
No abstract available.
3.
Hoffman-Censits J, Lombardo K, McConkey D, Hahn N, Bashir B, Kelly W, et al.
Urol Oncol
. 2021 Jun;
39(10):619-622.
PMID: 34148797
Enfortumab vedotin (EV) was FDA approved in December 2019 for platinum- and checkpoint-refractory urothelial cancer based on an exceptional 44% response rate, and is currently approved for use after platinum...